1-20 of 57
Keywords: Dexamethasone
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Neuroendocrinology (2022) 112 (4): 384–398.
Published Online: 29 March 2022
... (GSK3β)- and glucocorticoid (GC)-dependent pathways in the entrainment of clocks in individual HPC regions, CA1-3, and dentate gyrus (DG). Methods: The role of GCs was addressed in vivo by comparing the effects of adrenalectomy (ADX) and subsequent dexamethasone (DEX) supplementation on clock gene...
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Neuroendocrinology (1993) 57 (5): 856–862.
Published Online: 08 April 2008
... dexamethasone treatment with a single, high-dose injection. The purpose of the present study was to investigate whether a general upregulation of angiotensinogen expression or a region-specific upregulation underlies these findings. By using in situ hybridization and computer-assisted microdensitometry we...
Journal Articles
Neuroendocrinology (1992) 55 (6): 708–713.
Published Online: 07 April 2008
... in Krebs-Ringer bicarbonate buffer, medial basal hypothalami (MBH) were preincubated for 30 min with dexamethasone (DEX), a phospholipase A 2 (PLA 2 ) inhibitor, to block arachidonic acid (AA) formation, or with inhibitors of AA metabolism: a cyclooxygenase inhibitor – indomethacin (IND); a lipoxygenase...
Journal Articles
Neuroendocrinology (1992) 55 (6): 648–654.
Published Online: 07 April 2008
... perifused anterior pituitary cells in a dose-dependent manner, between 1.5 and 6 p M . This stimulatory action of IL-1 on ACTH was significantly attenuated by a short in vitro dexamethasone pretreatment. This fact suggests a regulatory glucocorticoid negative feedback analogous to that observed upon...
Journal Articles
Neuroendocrinology (1992) 55 (4): 468–476.
Published Online: 07 April 2008
...Daniel Biron; Charles Dauphin; Thérèse Di Paolo The effects of adrenalectomy (ADX) and dexamethasone (DEX) treatment on brain dopamine (DA) receptors of ovariectomized (OVX) rats were investigated by autoradiography using binding of the Dl and D2 antagonists ligands [ 3 H]SCH 23390 and [ 3 H...
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Neuroendocrinology (1990) 51 (3): 255–260.
Published Online: 03 April 2008
... secretion at all times. The peripheral 5-HT 2 antagonist xylamidine (100 µg/kg, i.v.) attenuated the corticosterone response elicited 15 min after DOI but did not alter the 60-min response. In contrast, dexamethasone pretreatment (350 µg/kg, s.c.) attenuated the corticosterone response to DOI at 15 min...
Journal Articles
Neuroendocrinology (1990) 51 (2): 181–189.
Published Online: 03 April 2008
... for glucocorticoids: type I corticosterone/cortisol-preferring, predominantly hippocampal receptors, and type II dexamethasone-binding receptors with a much broader distribution. To determine the relative roles played by these two receptors in determining basal and stress-induced ACTH/cortisol levels in the sheep, we...
Journal Articles
Journal Articles
Journal Articles
Neuroendocrinology (1990) 51 (1): 51–58.
Published Online: 03 April 2008
... tests each: placebo treatment (control); dexamethasone (Dex) administration 4 mg i.v., 3 h before; Dex 8 mg p.o., 12 h before, and Dex 22 mg p.o. over the 2 days before the pituitary challenge that was always administered at 0 min (12.00 h). In the first test (n = 9), GHRH (1 µg/kg i.v.) induced a GH...